Development of Novel Antibodies Against Functional Glycopeptides

「Through joint research with 医化学創薬株式会社 (hereinafter, 医化学創薬), we will develop specific antibodies against targets including osteopontin. 医化学創薬 possesses proprietary, advanced glycan synthesis technology, which enables the synthesis of functional glycopeptides that had previously been difficult to produce. By using these glycopeptides as antigens to create specific antibodies, we will also be able to produce antibodies with unprecedented specificity and binding affinity.」